Table 1.
Demographic, medical, neuropsychological, and laboratory values for all subjects.
| HIV- (n=21) | HIV+/cART+ (n=21) | HIV+/cART- (n=21) | |
|---|---|---|---|
| Age (years) | 39 (12) | 41 (14) | 38 (13) |
| Education (years) | 13 (2) | 13 (3) | 13 (2) |
| Sex (% male) | 91 | 91 | 91 |
| CD4 (cells/μL) | N/A | 384 (264, 583) | 371 (278, 474) |
| CD4 nadir (cells/μL) | N/A | 127 (27, 293) | 320 (228, 411)a |
| Log Plasma HIV viral Load | N/A | 1.93 (0.50) | 3.95 (0.84)a |
| % Virologically suppressed (% <50 copies/mL) | N/A | 71 | N/A |
| NPZ-4 score | −0.21 (0.96) | −0.50 (1.2) | −0.70 (0.77) |
| Self –reported duration of Infection (months) | N/A | 54 (56) | 18 (18)a |
| Duration on cART (months) | N/A | 25 (23) | N/A |
All errors are reported as standard deviation of the mean, and quartiles for laboratory values.
cART: combination antiretroviral therapy, NPZ-4: neuropsychological performance z score
a
HIV+/cART- vs HIV+/ART-, p ≤ 0.02.